Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Yunnan Multiple Myeloma Active Trials & Centers
As of 2026-09-04, there are 13 active clinical trials for multiple myeloma hosted across 7 tertiary medical centers in Yunnan (including The First Affiliated Hospital of Kunming Medical University, Yunnan First People's Hospital, The Second Affiliated Hospital of Kunming Medical University, etc.).
Participating Medical Centers (7)
Active Studies in Yunnan (13)
Population synthesized by CMDNShowing 0 published English records of 13 registry trials.
All 13 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.